PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Interestingly, the impact of the variant on the protection against NAFLD was larger in carriers of the PNPLA3 I148M variant, suggesting the two risk factors interact in the pathogenesis of this condition.